Commerce Bank’s TG Therapeutics TGTX Stock Holding History

Commerce Bank’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,393	Closed	-$266K	–	1251
2025 Q2	$266K	Sell	7,393 -1,700	-19%	-$63.3K	﹤0.01%	1077
2025 Q1	$359K	Buy	9,093 +2,304	+34%	+$77.5K	﹤0.01%	956
2024 Q4	$204K	Buy	+6,789	New	+$195K	﹤0.01%	1138
2021 Q2	–	Sell	-4,428	Closed	-$213K	–	1161
2021 Q1	$213K	Hold	4,428	–	–	﹤0.01%	1088
2020 Q4	$230K	Buy	+4,428	New	+$150K	﹤0.01%	1009

Other funds holding TGTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Commerce Bank's TGTX Position: Q3 2025 in Review

Commerce Bank sold out of TG Therapeutics (TGTX) in Q3 2025, closing a stake of 7,393 shares — an estimated $266K sold.

Commerce Bank first reported a position in TGTX in Q4 2020 and held it in 5 quarters. The position peaked at $359K in Q1 2025. 354 funds tracked by Wall St. Rank hold TGTX as of Q3 2025.

Commerce Bank reported no remaining TG Therapeutics position as of Q3 2025 after selling out during the quarter.
Commerce Bank sold 7,393 TG Therapeutics shares in Q3 2025, an estimated $266K.
Commerce Bank first reported a position in TG Therapeutics in Q4 2020 and held it in 5 quarters.
Commerce Bank's TG Therapeutics position peaked at $359K in Q1 2025.
354 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2025.

Based on Commerce Bank's 13F filing for Q3 2025, filed 12 Nov 2025.